Insight Partners, a venture capital and private equity firm, led an $80m Series C funding round in Florence, a site connectivity platform in clinical trials. Other investors include Fulcrum Equity Partners, Bee Partners, and Flashpoint. "Remote connectivity and virtual collaboration became a requirement after COVID-19. With one in three study sites around the world using our software, we were able to help. Not only do pharmaceutical companies, clinical research organizations, and sites use Florence to manage their COVID studies, they also leveraged our software to ensure that hundreds of other clinical trials across every disease area were able to progress as the industry pivoted to remote work. This investment will allow us to continue connecting research stakeholders, advancing cures, and giving investigators more time for who matters most: patients," Ryan Jones, Florence Co-Founder and CEO.